have taken the pfizer vaccine. meanwhile, t covid vaccine for children ages to 11, submitting trial data to e fda for review after recently determining the vaccine is safe and well tolerated. nbc news correspondent gabe gutierrez has the latest. reporter: with millions of children now back in classrooms, pfizer submitted data for the fda for 5 through 11 year olds, a crucial step towardsmergen use auorization. another barrier of protection r the little ones. eporter: pfizer s ceo with nbc s craig melvin who asked him for even youer children under 5. within a couple months we should be in a position to give update. before the end of the year. reporter: the 5 to 11-year-old children in pfizer s trial were given two small doses of the vaccine than those given 12 and older. the company says a smaller de has produced anti-dose
the fda said can be offered to the immunocompromised. do you think this whole rollout of the boosters has been a little confusing? extremely confusing. in fact, when we came in this morning, and they said you can t have the moderna because it s not yet been approveds has the pfizer, a little bit vexed and thought, well, we wasted a trip down here. but then, when we said we were immunocompromised, they said we could have the shot. and as i reported last night for the associated press, the pfizer dose for children, though there will be some hope it could be halloween, likely november. but hopefully more towards the early to middle of the month, rather than waiting till thanksgiving. we ll stay on that story. still ahead, the playoff picture for major league baseball is taking final shape. the latest on the wildcard race,
on the verge of concluding tria that mix doses from pfer, moderna and johnson & johnson. during a white house covid briefing yesterday, dr. anthony fauci says that data will be available within the next two weeks. the miss and match studyt which you look at moderna as the boostgainst the other three, those dat are now available. the j&js the boost for the other three likely will be available literally within a week, a few days to a week. and the data at looking at pfizer as the boost tthe other three will be available someere in the first week, or at the most, two o october. . that s when the data will be available. of course, with all things that we do they must be submitted to the fda for the recommended approval. so far, 2.7 million americans